Apple® will introduce StandBy Mode and Assistive Access Mode in the upcoming iOS 17 release. These new modes may impact your experience with your FreeStyle LibreLink◊ or FreeStyle Libre 3 app.◊◊
A member of our Customer Services team will then get in touch to help.
GB Mainland: 3 day delivery
Northern Ireland: 3-4 day delivery
(Estimated standard delivery)
All payments are secure and encrypted
Your cart is empty
FreeStyle Libre sensors
hours of glucose readings
more Time in Range
Comparing two groups from lowest to highest scan rate6, people who scanned more frequently using the
FreeStyle Libre system spent 43% more Time in Range.
Frequent use of the FreeStyle Libre system also resulted in people spending 26% less Time Below Range
(<3.0 mmol/L)5
Not only do FreeStyle Libre users scan more frequently at first5, they continue to do so over time7. This significantly reduces hypoglycaemia in people with both Type 11 and Type 22 diabetes.
FreeStyle Libre users scan more frequently, resulting in improved glucose control.5
The ABCD Nationwide Audit8 explored the real-world experiences of FreeStyle Libre users in the UK. It looked at the impact of glycaemic control for 3,182 adults with Type 1 or Type 2 diabetes.
patients with T1D & T2D
n=3182
Average reduction in HbA1c
-5.2 mmol/mol change in HbA1c, for FreeStyle Libre users starting with a baseline of 67.5 (+ - 20.9) mmol/mol
Average reduction in HbA1c
for FreeStyle Libre users starting with a baseline of >=69.5 mmol/mol8
HbA1c reduction was greater in those with initial HbA1c >= 69.5 mmol/mol (>8.5%), reducing from 85.5 (+/- 16.1) mmol/mol (10%) to 73.1 (+/- 15.8) mmol/mol (8.8%) (P < 0.0001).
Discover how the FreeStyle Libre family of apps and devices connect together to help you manage your diabetes better.
Scan your FreeStyle Libre 2 sensor and get glucose readings on your phone◊
Share your glucose data with friends, family and caregivers§
Our cloud-based diabetes management system for you and your Healthcare Team₼
* FreeStyle Libre portfolio refers to the FreeStyle Libre system, FreeStyle Libre 2 system and FreeStyle Libre 3 system
◊ The FreeStyle LibreLink app is only compatible with certain mobile devices and operating systems. Please check the website for more information about device compatibility before using the app. Use of FreeStyle LibreLink requires registration with LibreView.
§ The LibreLinkUp app is only compatible with certain mobile device and operating systems. Please check www.librelinkup.com for more information about device compatibility before using the app. Use of LibreLinkUp and FreeStyle LibreLink requires registration with LibreView. The LibreLinkUp mobile app is not intended to be a primary glucose monitor: home users must consult their primary device(s) and consult a healthcare professional before making any medical interpretation and therapy adjustments from the information provided by the app.
₼ The LibreView website is only compatible with certain operating systems and browsers. Please check www.libreview.com for additional information.
1. Bolinder J, Antuna R, Geelhoed-Duijvestijn P, Kr ger J, Weitgasser R. Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial. Lancet. 2016;388(10057):2254-2263.
2. Haak T, Hanaire H, Ajjan R, Hermanns N, Riveline JP, Rayman G. Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial. Diabetes Ther. 2017;8(1): 55-73.
3. Yaron M, Roitman E, Aharon-Hananel G, et al. Effect of flash glucose monitoring technology on glycemic control and treatment satisfaction in patients with type 2 diabetes. Diabetes Care. 2019;42(7):1178-1184. 2020;43(2):389-397.
4. Fokkert M, van Dijk P, Edens M, et al. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diab Res Care. 2019. https://doi:10.1136/bmjdrc-2019-000809.
5. Lang J, Jangam S, Dunn T, Hayter G. Expanded real-world use reaffirms strong correlation between scanning frequency of flash glucose monitoring and glucose control [Poster 972]. Diabetes. 2019;68(suppl 1). https://doi.org/10.2337/db19-972-P.
6. Comparing 2 groups from lowest to highest scan rate (3.6 and 39.5 scans/day).
7. Jangam S, Dunn T, Xu Y, Hayter G, Ajjan R. Flash glucose monitoring improves glycemia in higher-risk patients: a longitudinal, observational study under real-life settings. BMJOpen Diab Res Care 2019;7:e000611. DOl:10.1136/bmjdrc-2018-000611.
8. Deshmukh H, et al. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit. Diabetes Care 2020;43:2153–2160.
The “Yes” link below will take you to a website other than Abbott Laboratories. Links pointing you to other websites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the content of such websites or other links contained on such website. Abbott Laboratories provides these links only as a courtesy and the inclusion of any link does not imply endorsement by Abbott Laboratories of the site.
Do you want to leave this page?
FreeStyle.abbott/uk-en is a product specific website only intended for residents of the United Kingdom. If you live in another country, please contact your local Abbott office to obtain the correct product information for your country of residence.
